|
|
|
|
|
survival of motor neuron 2 splicing modifiers |
|
sympathomimetics |
|
synthetic BH4 |
|
synthetic vitamin d3 analogues |
|
|
|
T-cell engagers |
|
tetracyclic antidepressants |
|
|
|
|
|
|
|
thiazolidinediones |
|
thienobenzodiazepines |
|
|
|
|
|
|
|
|
|
trace metals |
|
|
|
|
|
|
|
tryptophan hydroxylase inhibitors |
|
|
|
urease inhibitors |
|
urinary tract analgesics |
|
|
|
vascular endothelial growth factor antagonists, monoclonal antibodies, angiopoietin-2 inhibitors |
|
|
|
vasodilators, nitrates |
